Guggenheim Reaffirms “Buy” Rating for Teva Pharmaceutical Industries Ltd. (TEVA)
Teva Pharmaceutical Industries Ltd. (TEVA) | December 28, 2016
Guggenheim reissued their buy rating on shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) in a report released on Friday. The firm currently has a $80.00 target price on the stock…